Nyxoah (NASDAQ:NYXH – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on Thursday, March 13th. Analysts expect the company to announce earnings of ($0.46) per share and revenue of $2.02 million for the quarter.
Nyxoah Price Performance
NASDAQ NYXH opened at $9.95 on Wednesday. Nyxoah has a fifty-two week low of $6.76 and a fifty-two week high of $20.00. The stock’s 50-day moving average is $10.21 and its two-hundred day moving average is $9.16. The company has a debt-to-equity ratio of 0.21, a current ratio of 5.28 and a quick ratio of 4.95. The firm has a market cap of $338.90 million, a P/E ratio of -5.32 and a beta of 1.42.
Analysts Set New Price Targets
Separately, HC Wainwright restated a “buy” rating and set a $17.00 price target on shares of Nyxoah in a research note on Friday, December 13th.
About Nyxoah
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
See Also
- Five stocks we like better than Nyxoah
- What Are Dividend Achievers? An Introduction
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What Are Dividend Challengers?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Canadian Penny Stocks: Can They Make You Rich?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
